Transgenic Group Inc. (TYO:2342)
Japan · Delayed Price · Currency is JPY 220.00
+6.00 (2.80%)
Aug 6, 2026, 2:15 PM JST
Transgenic Group Market Cap
Transgenic Group has a market cap or net worth of 3.56 billion as of August 5, 2026. Its market cap has increased by 5.94% in one year.
Market Cap
3.56B
Enterprise Value
3.58B
Revenue
13.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
220.00
ChartMarket Cap Chart
Since July 2, 2003, Transgenic Group's market cap has decreased from 9.78B to 3.56B, a decrease of -63.55%. That is a compound annual growth rate of -4.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 3.56B | -29.84% |
| Dec 30, 2025 | 5.08B | 73.30% |
| Dec 30, 2024 | 2.93B | -33.27% |
| Dec 29, 2023 | 4.39B | -20.08% |
| Dec 30, 2022 | 5.50B | -27.38% |
| Dec 30, 2021 | 7.57B | -5.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Soiken Holdings | 5.60B |
| Chiome Bioscience | 5.45B |
| Cyfuse Biomedical K.K. | 5.06B |
| Kohjin Bio | 4.47B |
| TMS Co., Ltd. | 4.47B |
| D. Western Therapeutics Institute | 4.37B |
| Ribomic | 4.13B |
| Human Metabolome Technologies | 3.29B |